Literature DB >> 21283471

Osteoporosis: an update on pathogenesis and treatment.

R G Josse.   

Abstract

Both hormonal and nonhormonal factors appear to contribute to bone loss in osteoporosis. Decreased estrogen production, not enough calcium and too much protein, phosphorus and caffeine in the diet all have a probable effect. Aims of treatment include giving symptomatic relief, rehabilitation, arresting further bone loss, increasing the useful bone mass and restoring damaged skeletal architecture where possible. Current treatment includes ensuring that the patient avoids excess protein and caffeine and has adequate calcium in her diet. Estrogen therapy is still subject to debate, but does seem to prevent bone loss if initiated within three to five years of menopause. Much research is currently being done on sodium fluoride, the only agent that appears actually able to produce new bone.

Entities:  

Year:  1983        PMID: 21283471      PMCID: PMC2154301     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  20 in total

1.  Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women.

Authors:  J C Gallagher; E C Nordin
Journal:  Front Horm Res       Date:  1975       Impact factor: 2.606

2.  Effect of estrogens and calcium carbonate on bone loss in postmenopausal women.

Authors:  R R Recker; P D Saville; R P Heaney
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

3.  The crush fracture syndrome in postmenopausal women.

Authors:  J C Gallagher; J Aaron; A Horsman; D H Marshall; R Wilkinson; B E Nordin
Journal:  Clin Endocrinol Metab       Date:  1973-07

4.  Studies in calcium metabolism. I. The calciuretic effect of dietary protein.

Authors:  S Margen; J Y Chu; N A Kaufmann; D H Calloway
Journal:  Am J Clin Nutr       Date:  1974-06       Impact factor: 7.045

Review 5.  Osteoporosis. Its nature and the role of diet.

Authors:  J Jowsey
Journal:  Postgrad Med       Date:  1976-08       Impact factor: 3.840

6.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

7.  Prospective trial of oestrogen and calcium in postmenopausal women.

Authors:  A Horsman; J C Gallagher; M Simpson; B E Nordin
Journal:  Br Med J       Date:  1977-09-24

8.  Calcium balance and calcium requirements in middle-aged women.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  Am J Clin Nutr       Date:  1977-10       Impact factor: 7.045

9.  Osteoporosis after oophorectomy for non-malignant disease in premenopausal women.

Authors:  J M Aitken; D M Hart; J B Anderson; R Lindsay; D A Smith; C F Speirs
Journal:  Br Med J       Date:  1973-05-12

10.  Clinical significance and pathogenesis of osteoporosis.

Authors:  B E Nordin
Journal:  Br Med J       Date:  1971-03-13
View more
  4 in total

1.  Calcium compounds for treating osteoporosis.

Authors:  J K Hay
Journal:  Can Fam Physician       Date:  1984-02       Impact factor: 3.275

2.  Osteoporosis: prevention and management strategies.

Authors:  S Evers; A Myers
Journal:  Can Fam Physician       Date:  1987-01       Impact factor: 3.275

3.  Identifying postmenopausal patients at risk of significant bone loss.

Authors:  J W Orchard; S E Evers; R G Haddad
Journal:  Can Fam Physician       Date:  1984-12       Impact factor: 3.275

4.  Protocatechuic Acid Attenuates Trabecular Bone Loss in Ovariectomized Mice.

Authors:  Seon-A Jang; Hae Seong Song; Jeong Eun Kwon; Hyun Jin Baek; Hyun Jung Koo; Eun-Hwa Sohn; Sung Ryul Lee; Se Chan Kang
Journal:  Oxid Med Cell Longev       Date:  2018-07-29       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.